Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVATIO for Pulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 153 adverse event reports in the FDA FAERS database where REVATIO was used for Pulmonary hypertension.

Most Reported Side Effects for REVATIO

Side Effect Reports % Deaths Hosp.
Death 79 18.2% 79 3
Pulmonary hypertension 44 10.1% 39 10
Dyspnoea 41 9.5% 6 14
Cardiac failure 26 6.0% 19 6
Fall 21 4.8% 2 10
Pneumonia 20 4.6% 10 9
Malaise 17 3.9% 1 6
Cardiac disorder 14 3.2% 6 3
Respiratory failure 13 3.0% 13 4
Fluid retention 11 2.5% 1 10
Hypotension 10 2.3% 4 6
Off label use 10 2.3% 5 2
Chronic obstructive pulmonary disease 9 2.1% 5 1
Myocardial infarction 9 2.1% 5 1
Cardiac failure congestive 8 1.8% 7 3

Other Indications for REVATIO

Pulmonary arterial hypertension (111) Product used for unknown indication (8) Cardiac disorder (6)

Other Drugs Used for Pulmonary hypertension

AMBRISENTAN (18,885) TREPROSTINIL (10,034) MACITENTAN (5,228) RIOCIGUAT (3,837) SILDENAFIL (3,761) SELEXIPAG (2,500) EPOPROSTENOL (2,486) TADALAFIL (2,430) BOSENTAN (2,337) ILOPROST (1,123)

Related Pages

REVATIO Full Profile All Pulmonary hypertension Drugs REVATIO Demographics REVATIO Timeline